<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02980614</url>
  </required_header>
  <id_info>
    <org_study_id>PI2016_843_0026</org_study_id>
    <nct_id>NCT02980614</nct_id>
  </id_info>
  <brief_title>4D Velocity Mapping of the Heart in rTOF Patients</brief_title>
  <acronym>CARDIOFLUX</acronym>
  <official_title>Cardiac 4D MR Velocity Mapping in Repaired Tetralogy of Fallot Patients: Evaluation of Pulmonary Regurgitant Fraction and Ventricular Volume</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MRI with 4D flow permits to assess the hemodynamic parameters in a parent vessel and its
      branches inside the same sequence. The objective of the project is to compare the regurgitant
      fraction in the pulmonary artery (PA) measured using 4D MR-flow and standard 2D MR-flow in
      repaired Tetralogy of Fallot (rTOF) patients. The consistency of the 4D flow quantization
      will be assessed assuming mass conservation in the pulmonary artery tree (PA flow =LeftPA
      flow +RightPA flow ? ).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Regurgitant fraction comparison</measure>
    <time_frame>Day 0</time_frame>
    <description>The primary objective of the project is to compare the regurgitant fraction in the pulmonary artery (PA) measured with 4D MR-flow and standard 2D MR-flow.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Right ventricular volume</measure>
    <time_frame>Day 0</time_frame>
    <description>The secondary objective is to compare the right ventricular volumes measured using the 4D prototype and the standard steady-state free precession sequences.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary arteries flows</measure>
    <time_frame>Day 0</time_frame>
    <description>The consistency of the 4D flow quantization will be assessed assuming mass conservation in the pulmonary artery (PA) tree (PA flow =LeftPA flow +RightPA flow ? ).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Magnetic Resonance Imaging</condition>
  <condition>Tetralogy of Fallot</condition>
  <arm_group>
    <arm_group_label>Participants to 4D flow imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to the standard clinical MR protocol, 2 added sequences:
4D MR sequence in cine mode 4D velocity mapping sequence</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>4D flow imaging</intervention_name>
    <arm_group_label>Participants to 4D flow imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tetralogy of Fallot patients

          -  referred for clinical MRI examination

          -  â‰¥ 15 years

        Exclusion Criteria:

          -  Anyone with a classic contraindication to MRI

          -  Severe obesity

          -  Gadolinium chelate allergy

          -  &lt; 15 years

          -  counter-indication to MRI examination

          -  vulnerable person
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cedric Renard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cedric Renard, MD</last_name>
    <phone>+33 3 22 08 75 37</phone>
    <email>renard.cedric@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cedric Renard, MD</last_name>
      <phone>+33 3 22 08 75 37</phone>
      <email>renard.cedric@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Amel Mathiron, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2016</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>phase-contrast MRI</keyword>
  <keyword>blood flow</keyword>
  <keyword>velocity mapping</keyword>
  <keyword>Quantitative MRI</keyword>
  <keyword>Cardiac imaging</keyword>
  <keyword>Tetralogy of Fallot</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetralogy of Fallot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

